About Peter Thompson
Peter Thompson is a co-founder and director, terremoto at Terremoto Biosciences.
Peter Thompson reports to the SEC as a director, officer or major shareholder of 17 public companies, including Sionna Therapeutics (SION), ARS Pharmaceuticals (SPRY) and Edgewise Therapeutics (EWTX).
Peter Thompson first appears on SEC filings in 2006.
Experience
This experience comes from Peter Thompson's profile and from SEC filings. For roles taken from filings, the years are when the filings name Peter Thompson in the role, so the role may have started earlier or lasted longer.
Terremoto Biosciences, Inc. Current
Co-founder and Director, Terremoto
Chairman, Co-Founder (2021 – Present)
2021 – Present · South San Francisco, CA
Develops targeted medicines for patients with cancer and genetic diseases.
EI
Edgewise Therapeutics, Inc. Current
Director and 10% owner
Chairman, Co-Founder (2017 – Present)
2017 – Present · Public company (EWTX)
ST
Silverback Therapeutics Current
Co-Founder, Chairman
2016 – Present
CI
Corvus Pharmaceuticals, Inc. Current
Director and 10% owner
Co-Founder, Director (2014 – Present)
2014 – Present · Public company (CRVS)
OA
OrbiMed Advisors Current
General Partner
2010 – Present
CB
Cleave BioSciences Current
Co-Founder, Director
2010 – Present
UW
University of Washington Current
Affiliate Professor, Neurosurgery
2010 – Present
SI
Sionna Therapeutics, Inc.
Director
2025 – 2026 · Public company (SION)
AI
ARS Pharmaceuticals, Inc.
Director and 10% owner
2020 – 2026 · Public company (SPRY)
AI
Alpine Immune Sciences, Inc.
Director and 10% owner
2017 – 2024 · Public company (ALPN)
DI
Decibel Therapeutics, Inc.
Director and 10% owner
2021 – 2022 · Public company (DBTX)
JI
Janux Therapeutics, Inc.
Director and 10% owner
2021 – 2022 · Public company (JANX)
PI
PMV Pharmaceuticals, Inc.
Director and 10% owner
2020 – 2021 · Public company (PMVP)
PI
Prevail Therapeutics Inc.
Director and 10% owner
2019 – 2021 · Public company (PRVL)
SI
Synthorx, Inc.
Director and 10% owner
2018 – 2020 · Public company (THOR)
PI
Principia Biopharma Inc.
Chairman of the Board
2013 – 2019 · Public company (PRNB)
AP
Adaptimmune Therapeutics PLC
Director
2016 – 2018 · Public company (ADAP)
RC
Response Biomedical Corp.
Interim Chief Exec Officer and director
2012 – 2016 · Public company (RBM)
SI
Sierra Oncology, Inc.
Director
2015 · Public company (SRRA)
MI
Mirati Therapeutics, Inc.
Director
2013 · Public company (MRTX)
SP
Strategicon Partners
CEO, Managing Director
2001 – 2013
AI
Anthera Pharmaceuticals Inc
Director
2011 – 2012 · Public company (ANTH)
TI
Trubion Pharmaceuticals, Inc
President and CEO, director
Co-Founder, Chairman, CEO (2002 – 2009)
2002 – 2009 · Public company (TRBN)
AC
ATP Capital
Venture Partner
2002 – 2005
CC
Chiron Corporation
VP, GM Chiron Informatics
1995 – 1999
BD
BD
VP, R&D
1991 – 1995
NI
National Cancer Institute
Lab Head
1985 – 1992
Key Colleagues at Startups
The people Peter Thompson works with at each company, as listed on that company's latest Form D.
Terremoto Biosciences, Inc. · Form D, Apr 22, 2026
MG
Michael Goller
Director
GL
Grace Lu
Executive officer
James Christensen
President and Chief Executive Officer, director
Reid Huber
Partner, Third Rock Ventures and director
DC
Daniel O'Connell
Director
Charles Baum
Executive Chairman